MC
FLACW

Meteora Capital’s Frazier Lifesciences Acquisition Corporation Warrant FLACW Stock Holding History

Meteora Capital’s Portfolio FLACW Stock Details FLACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,328
Closed -$1K – 536
2022
Q2 		$1K Buy
+10,328
New +$1.79K ﹤0.01% 484

Other funds holding FLACW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
ETH
Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $672M AUM 71.14% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
AI
Arena Investors Purchase, New York $12.5M AUM 0.27% 1-Year Est. Return

Meteora Capital's FLACW Position: Q3 2022 in Review

Meteora Capital sold out of Frazier Lifesciences Acquisition Corporation Warrant (FLACW) in Q3 2022, closing a stake of 10,328 shares — an estimated $1K sold.

Meteora Capital first reported a position in FLACW in Q2 2022 and held it in 1 quarter. The position peaked at $1K in Q2 2022. 21 funds tracked by Wall St. Rank hold FLACW as of Q3 2022.

  • Meteora Capital reported no remaining Frazier Lifesciences Acquisition Corporation Warrant position as of Q3 2022 after selling out during the quarter.
  • Meteora Capital sold 10,328 Frazier Lifesciences Acquisition Corporation Warrant shares in Q3 2022, an estimated $1K.
  • Meteora Capital first reported a position in Frazier Lifesciences Acquisition Corporation Warrant in Q2 2022 and held it in 1 quarter.
  • Meteora Capital's Frazier Lifesciences Acquisition Corporation Warrant position peaked at $1K in Q2 2022.
  • 21 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Warrant as of Q3 2022.

Based on Meteora Capital's 13F filing for Q3 2022, filed 14 Nov 2022.